Syndax Net Tangible Assets vs Accounts Payable Analysis

SNDX Stock  USD 16.09  0.49  3.14%   
Syndax Pharmaceuticals financial indicator trend analysis is much more than just breaking down Syndax Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Syndax Pharmaceuticals is a good investment. Please check the relationship between Syndax Pharmaceuticals Net Tangible Assets and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Syndax Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Syndax Stock please use our How to Invest in Syndax Pharmaceuticals guide.

Net Tangible Assets vs Accounts Payable

Net Tangible Assets vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Syndax Pharmaceuticals Net Tangible Assets account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Syndax Pharmaceuticals' Net Tangible Assets and Accounts Payable is 0.86. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Syndax Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Syndax Pharmaceuticals' Net Tangible Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Syndax Pharmaceuticals are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Tangible Assets i.e., Syndax Pharmaceuticals' Net Tangible Assets and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.86
Relationship DirectionPositive 
Relationship StrengthStrong

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Accounts Payable

An accounting item on the balance sheet that represents Syndax Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Syndax Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Syndax Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Syndax Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Syndax Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Syndax Stock please use our How to Invest in Syndax Pharmaceuticals guide.At this time, Syndax Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 1.3 B in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 137.9 M in 2024.

Syndax Pharmaceuticals fundamental ratios Correlations

-0.30.920.761.00.910.9-0.93-0.930.880.930.840.321.00.310.94-0.170.680.970.630.931.0-0.640.970.980.47
-0.3-0.33-0.15-0.31-0.38-0.360.260.51-0.4-0.18-0.42-0.15-0.30.42-0.350.110.01-0.370.0-0.34-0.290.5-0.24-0.28-0.76
0.92-0.330.90.920.90.95-0.92-0.880.940.910.960.190.910.340.81-0.40.420.920.580.910.91-0.550.90.930.33
0.76-0.150.90.750.740.85-0.78-0.70.810.80.890.030.750.590.63-0.50.230.770.650.750.75-0.150.740.780.14
1.0-0.310.920.750.90.9-0.93-0.920.870.920.840.351.00.290.95-0.180.690.960.60.931.0-0.650.970.980.47
0.91-0.380.90.740.90.82-0.9-0.930.960.880.770.190.910.270.82-0.170.590.950.610.990.91-0.680.940.940.49
0.9-0.360.950.850.90.82-0.82-0.810.820.810.950.420.890.370.86-0.570.480.860.440.860.89-0.470.830.880.25
-0.930.26-0.92-0.78-0.93-0.9-0.820.88-0.92-0.99-0.830.0-0.93-0.23-0.770.13-0.46-0.91-0.65-0.91-0.930.61-0.91-0.91-0.45
-0.930.51-0.88-0.7-0.92-0.93-0.810.88-0.91-0.85-0.8-0.23-0.93-0.15-0.880.05-0.59-0.98-0.66-0.92-0.930.72-0.94-0.95-0.64
0.88-0.40.940.810.870.960.82-0.92-0.910.910.850.030.870.240.74-0.210.390.910.620.940.87-0.640.890.90.48
0.93-0.180.910.80.920.880.81-0.99-0.850.910.82-0.020.920.280.75-0.130.450.90.660.90.92-0.560.910.910.39
0.84-0.420.960.890.840.770.95-0.83-0.80.850.820.210.830.290.74-0.550.260.820.460.790.83-0.430.770.820.3
0.32-0.150.190.030.350.190.420.0-0.230.03-0.020.210.330.190.59-0.310.670.26-0.140.240.33-0.280.290.320.02
1.0-0.30.910.751.00.910.89-0.93-0.930.870.920.830.330.310.95-0.150.70.970.630.931.0-0.640.980.980.48
0.310.420.340.590.290.270.37-0.23-0.150.240.280.290.190.310.3-0.320.290.290.590.310.310.350.330.34-0.29
0.94-0.350.810.630.950.820.86-0.77-0.880.740.750.740.590.950.3-0.160.820.910.530.850.95-0.640.920.930.49
-0.170.11-0.4-0.5-0.18-0.17-0.570.130.05-0.21-0.13-0.55-0.31-0.15-0.32-0.160.15-0.130.21-0.21-0.15-0.18-0.08-0.160.42
0.680.010.420.230.690.590.48-0.46-0.590.390.450.260.670.70.290.820.150.650.390.630.7-0.520.730.70.28
0.97-0.370.920.770.960.950.86-0.91-0.980.910.90.820.260.970.290.91-0.130.650.670.950.97-0.640.980.990.51
0.630.00.580.650.60.610.44-0.65-0.660.620.660.46-0.140.630.590.530.210.390.670.590.63-0.190.680.650.38
0.93-0.340.910.750.930.990.86-0.91-0.920.940.90.790.240.930.310.85-0.210.630.950.590.93-0.660.950.950.45
1.0-0.290.910.751.00.910.89-0.93-0.930.870.920.830.331.00.310.95-0.150.70.970.630.93-0.650.980.980.48
-0.640.5-0.55-0.15-0.65-0.68-0.470.610.72-0.64-0.56-0.43-0.28-0.640.35-0.64-0.18-0.52-0.64-0.19-0.66-0.65-0.66-0.65-0.6
0.97-0.240.90.740.970.940.83-0.91-0.940.890.910.770.290.980.330.92-0.080.730.980.680.950.98-0.660.990.45
0.98-0.280.930.780.980.940.88-0.91-0.950.90.910.820.320.980.340.93-0.160.70.990.650.950.98-0.650.990.44
0.47-0.760.330.140.470.490.25-0.45-0.640.480.390.30.020.48-0.290.490.420.280.510.380.450.48-0.60.450.44
Click cells to compare fundamentals

Syndax Pharmaceuticals Account Relationship Matchups

Syndax Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets63.5M300.6M449.7M497.2M612.9M643.5M
Other Current Liab10.2M11.2M14.7M24.3M47.1M49.4M
Total Current Liabilities18.4M18.9M20.7M29.1M58.1M61.0M
Total Stockholder Equity31.6M252.2M408.4M467.4M554.2M581.9M
Property Plant And Equipment Net997K482K1.3M1.1M1.5M1.6M
Net Debt(23.7M)(94.7M)(201.0M)(73.2M)(293.8M)(279.1M)
Retained Earnings(495.5M)(568.6M)(543.7M)(693.0M)(902.4M)(857.3M)
Accounts Payable6.2M3.5M5.7M4.4M10.0M10.5M
Cash24.6M115.2M222.0M74.4M295.4M310.2M
Non Current Assets Total1.2M1.7M1.3M16.0M32.0M33.6M
Non Currrent Assets Other82K1.2M983K9.4M680K646K
Cash And Short Term Investments59.8M293.1M439.9M481.3M577.6M606.5M
Common Stock Shares Outstanding30.5M41.3M53.6M60.8M70.4M38.8M
Short Term Investments35.2M177.8M218.0M410.0M282.2M296.3M
Liabilities And Stockholders Equity63.5M300.6M449.7M497.2M612.9M643.5M
Non Current Liabilities Total13.6M29.6M20.6M722K588K558.6K
Other Current Assets763K5.6M7.9M9.9M2.1M2.7M
Other Stockholder Equity527.1M820.8M952.0M1.2B1.5B1.5B
Total Liab31.9M48.4M41.3M29.8M58.7M34.5M
Property Plant And Equipment Gross997K482K1.7M1.5M1.9M2.0M
Total Current Assets62.3M298.9M448.4M481.3M580.9M609.9M
Accumulated Other Comprehensive Income(310K)(4K)45K(806K)218K228.9K
Short Term Debt478K2.6M362K439K1.0M994.7K
Common Stock3K5K6K7K8K8.4K
Other Liab17.1M14.8M13.1M11.6M13.4M14.2M
Net Tangible Assets31.6M252.2M408.4M467.4M537.6M564.4M
Other Assets219K0.01.6M922K829.8K472.8K
Net Receivables116K175K429K4.1M1.2M795.6K
Inventory1.7M5.3M7.7M(4.3M)2.0M1.6M
Property Plant Equipment997K192K278K1.1M1.2M1.3M
Retained Earnings Total Equity(439.4M)(495.5M)(568.6M)(543.7M)(489.3M)(513.8M)
Capital Surpluse492.5M527.1M820.8M952.0M1.1B669.6M
Non Current Liabilities Other136K5K11.7M711K817.7K776.8K
Net Invested Capital31.6M272.3M428.3M467.4M554.2M300.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Syndax Stock Analysis

When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.